Astraea Therapeutics Email Format

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Astraea Therapeutics is a small pharmaceutical company developing oral medicines intended to treat substance use disorders, including opioid dependency, nicotine addiction, and habitual psychostimulant use. Its work centers on relapse biology, with a platform that targets two brain pathways tied to addictive behavior and altered in addiction as indicated by clinical imaging.

Based in Sunnyvale, California, the company operates as a clinical-stage organization pursuing therapies for patients by addressing the neural drivers of addiction. Its focus lies in the brain mechanisms underlying relapse, guiding its approach to developing oral treatments. The small team size aligns with its early-stage status within the pharmaceutical development sector.

Sign up for free to view info

Company overview Employee directory